Dusa Pharmaceuticals (DUSA) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $56.65 --0%
Financial Fact:
Marketing and sales: 3.35M
Today's EPS Names:
ITGR, CARE, CCB, More
Financial Fact:
Marketing and sales: 3.35M
Today's EPS Names:
ITGR, CARE, CCB, More
Join SI Premium – FREE
Dusa Pharmaceuticals (NASDAQ: DUSA) reported Q2 EPS of $0.09, $0.07 better than the analyst estimate of $0.02. Revenue for the quarter came in at $9.76 million versus the consensus estimate of $10.3 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- InterDigital (IDCC) Tops Q3 EPS by 177c ; Offers Guidance
- Arrow Financial (AROW) Tops Q3 EPS by 3c
- Ameriprise Financial (AMP) Tops Q3 EPS by 30c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
